Epidemiology, Treatment Strategy, Natural Disease Course and Surgical Outcomes of Patients with Ulcerative Colitis in Western Hungary – A Population-based Study Between 2007 and 2018: Data from the Veszprem County Cohort

Author:

Kurti Zsuzsanna1,Gonczi Lorant1,Lakatos Laszlo2,Golovics Petra A3,Pandur Tunde4,David Gyula2,Erdelyi Zsuzsanna2,Szita Istvan2,Lakatos Peter L15ORCID

Affiliation:

1. Department of Internal Medicine and Oncology, Semmelweis University , Budapest , Hungary

2. Department of Gastroenterology, Ferenc Csolnoky Hospital , Veszprem , Hungary

3. Department of Gastroenterology, Hungarian Defence Forces Medical Centre , Budapest , Hungary

4. Department of Gastroenterology, Grof Eszterhazy Hospital , Papa , Hungary

5. Division of Gastroenterology, McGill University Health Center , Montreal, Quebec , Canada

Abstract

Abstract Background and Aims The number of population-based studies in ulcerative colitis [UC] from Eastern Europe is limited. Our aim here was to analyse the incidence, prevalence, disease phenotype, treatment strategy, disease course and colectomy rates in a prospective population-based inception cohort including UC patients diagnosed between 2007 and 2018. The present study is a continuation of the Veszprem IBD cohort since 1977. Methods In total, 467 UC patients were included [male/female: 236/231; median age at diagnosis: 36 years, IQR: 25–54 years]. Both in-hospital and outpatient records were collected and comprehensively reviewed. The mean length of follow-up was 8.34 ± 3.6 years. Demographic data were derived from the Hungarian Central Statistical Office. Results The mean incidence rate was 11.02/105 person-years in this 12-year period. Prevalence was 317.79/105 persons in 2015. Disease extent at diagnosis was proctitis [E1] in 22.3%, left-sided colitis [E2] in 43.9% and extensive colitis [E3] in 33.8%. The probability of disease extent progression was 11.6% [SE: 1.8] after 5 years. The distribution of maximal therapeutic steps was 5-ASA in 46.9%, corticosteroids in 16.3%, immunosuppressives in 19.3% and biologicals in 16.5%. The probability of receiving biological therapy after diagnosis was 9.9% [SE: 1.4] at 3 years. The overall colectomy rate was 4.1% in the population. The probability of colectomy was 1.5% [SE: 0.6] at 1 year, 3.6% [SE: 0.9] at 5 years and 4.4% [SE: 1.0] at 10 years. Conclusions The incidence of UC was high in Hungary, similar to high-incidence areas in Western Europe. Treatment strategies are in line with the biological era. The probability of progressing to proximal disease, and the medium- and long-term colectomy rates were both lower compared with data from Western European centres.

Funder

Ministry of Human Capacities

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Reference27 articles.

1. Epidemiology and pathogenesis of ulcerative colitis;Du;Gastroenterol Clin North Am,2020

2. Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review;Molodecky;Gastroenterology,2012

3. Epidemiology of inflammatory bowel diseases from west to east;Vegh;J Dig Dis,2017

4. Striking elevation in incidence and prevalence of inflammatory bowel disease in a province of western Hungary between 1977–2001;Lakatos;World J Gastroenterol,2004

5. Incidence, disease phenotype at diagnosis, and early disease course in inflammatory bowel diseases in Western Hungary, 2002–2006;Lakatos;Inflamm Bowel Dis,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3